Literature DB >> 6761568

High-dose cytosine arabinoside: clinical response to therapy in acute leukemia.

A P Early, H D Preisler, D J Higby, M Brecher, G Browman, J A McBride.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6761568     DOI： 10.1002/mpo.2950100725

Source DB:  PubMed          Journal:  Med Pediatr Oncol        ISSN： 0098-1532


× No keyword cloud information.
  4 in total

Review 1.  Cytosine arabinoside in the treatment of acute myeloid leukemia: the role and place of high-dose regimens.

Authors:  W Hiddemann
Journal:  Ann Hematol       Date:  1991-04       Impact factor: 3.673

Review 2.  Treatment strategies in acute myeloid leukemia (AML). B. Second line treatment.

Authors:  W Hiddemann; T Büchner
Journal:  Blut       Date:  1990-03

3.  Experience with human lymphoblastoid interferon in acute myelogenous leukaemia (AML).

Authors:  A Z Rohatiner; F R Balkwill; J S Malpas; T A Lister
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

4.  High-dose cytosine arabinoside: response to therapy in acute leukaemia and non-Hodgkin's lymphoma.

Authors:  A Rohatiner; M L Slevin; H S Dhaliwal; J S Malpas; T A Lister
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.